Entry Detail



General Information

Database ID:exR0201423
RNA Name:hsa-miR-1321
RNA Type:miRNA
Chromosome:chrX
Starnd:+
Coordinate:
Start Site(bp):85835832End Site(bp):85835849
External Links:hsa-miR-1321



Disease Information

Disease Name:Mild Cognitive Impairment
Disease Category:Other Diseases
MeSH ID:D060825
Type:Psychiatry and Psychology Category/Mental Disorders
Alias:Cognitive Dysfunction//Cognitive Dysfunctions//Dysfunction, Cognitive//Dysfunctions, Cognitive//Cognitive Impairments//Cognitive Impairment//Impairment, Cognitive//Impairments, Cognitive//Mild Cognitive Impairment//Cognitive Impairment, Mild//Cognitive Impairments, Mild//Impairment, Mild Cognitive//Impairments, Mild Cognitive//Mild Cognitive Impairments//Mild Neurocognitive Disorder//Disorder, Mild Neurocognitive//Disorders, Mild Neurocognitive//Mild Neurocognitive Disorders//Neurocognitive Disorder, Mild//Neurocognitive Disorders, Mild//Cognitive Decline//Cognitive Declines//Decline, Cognitive//Declines, Cognitive//Mental Deterioration//Deterioration, Mental//Deteriorations, Mental//Mental Deteriorations



Expression Detail

GEO ID:GSE120584
Description:Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data
Experimental Design:Disease vs Control
Case Disease Type:Alzheimer's Disease
Case Disease SubType:NA
Case Sample:Mild Cognitive Impairment
Control Sample:Normal
Number of Case:1021
Number of Control:288
Number of Samples:1309





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
DDAH1
chr1
85318481
85578363
-
WASF2
chr1
27404230
27490167
-
KDM5C
chrX
53191321
53225422
-
C19orf47
chr19
40319536
40348527
-
UBE2Q1
chr1
154548577
154559028
-
KLC2
chr11
66257294
66267860
+
CBFA2T3
chr16
88874858
88977207
-
ENSA
chr1
150600851
150629612
-
ZDHHC9
chrX
129803288
129843909
-
MKNK2
chr19
2037465
2051244
-
AKIRIN1
chr1
38991276
39006059
+
NRF1
chr7
129611720
129757082
+
REEP4
chr8
22138020
22141951
-
BCL7A
chr12
122019422
122062044
+
CBX5
chr12
54230942
54280133
-
SOX13
chr1
204073115
204127743
+
LENG8
chr19
54448887
54462037
+
CCND3
chr6
41934933
42050357
-
STK35
chr20
2101827
2177038
+
GPI
chr19
34359480
34402413
+
RCOR1
chr14
102592649
102730561
+
ONECUT2
chr18
57435374
57491298
+
SPTBN2
chr11
66685248
66729226
-
WSB2
chr12
118032694
118062430
-
ARID1A
chr1
26693236
26782104
+
HMGA1
chr6
34236873
34246231
+
RARA
chr17
40309180
40357643
+
TP53
chr17
7661779
7687550
-
TPP1
chr11
6612768
6619448
-
SCD
chr10
100347233
100364826
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC022167.2
chr16
8848105
8860456
+
AC069281.2
chr7
100572232
100578700
-
AC124068.2
chr15
89335053
89336161
+
AP000233.2
chr21
25095022
25103670
+
HCG18
chr6
30286690
30327382
-
KCNQ1OT1
chr11
2608328
2699994
-
MALAT1
chr11
65497688
65506516
+
MIR22HG
chr17
1711493
1717174
-
NEAT1
chr11
65422774
65445540
+
OIP5-AS1
chr15
41283990
41309737
+
TYMSOS
chr18
630886
658340
-
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE120584
Sample Source:Blood
Source Fraction:Serum
Platform:GPL21263
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:2532
Sample treatment protocol:NA
RNA Extract protocol:Total RNA was extracted each from 300uL serum samples using 3D-Gene® RNA extraction reagent from liquid sample kit (Toray Industries, Inc.).
RNA library preparation protocol:miRNA was labeled using 3D-Gene® miRNA Labeling kit in accordance with the manufacturer's instructions.



Reference

PMID:30820472
Title:Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data
Author:Shigemizu D, Akiyama S, Asanomi Y, Boroevich KA, Sharma A, Tsunoda T, Matsukuma K, Ichikawa M, Sudo H, Takizawa S, Sakurai T, Ozaki K, Ochiya T, Niida S
Journal:Commun Biol. 2019 Feb 25;2:77.
Description:we investigated potential miRNA biomarkers and constructed risk prediction models, based on a supervised principal component analysis (PCA) logistic regression method, according to the subtype of dementia